#Japan #Tokyo #Probiotics #Toa Pharmaceutical #Biosthree® VC

Introduction of Biosthree® VC

Toa Pharmaceutical Industry has recently announced the launch of Biosthree® VC, a groundbreaking new probiotic feed designed specifically for the livestock industry. This innovative product aims to set a new standard in probiotics for cattle, catering to the growing needs of farmers who strive for optimal cow health.

Effective Composition

Biosthree® VC contains a unique blend of three beneficial microorganisms that promote growth and active proliferation in the intestinal tract, along with activated yeast, known as VistaCell. This powerful combination is designed to simultaneously support both the rumen and intestinal health of cattle. By using Biosthree® VC, farmers no longer need to worry about administering separate products to address rumen and intestinal care, thus saving time and improving convenience.

Benefits of Using Biosthree® VC

1. Simplified Feeding Process: The product enables farmers to provide essential probiotics through one feed instead of administering multiple products. This greatly enhances usability and management.
2. Reduction in Overall Costs: By combining the benefits of both Biosthree and VistaCell, farmers can cut down on additional costs associated with purchasing and managing two separate products. This is particularly beneficial in streamlining operations and reducing expenditure.
3. Maintenance of Optimal Digestion: By supporting intestinal health, Biosthree® VC helps maintain optimal digestion, which translates to better overall health for livestock. Improved digestive performance may lead to a more favorable living environment in barns, contributing to better animal welfare.

Availability

Biosthree® VC is set to be available for shipment to manufacturers starting April 1, 2026, in a convenient 10-kg kraft bag format. As the unique formulas gain traction in livestock management practices, it will likely enhance productivity and financial outcomes for farmers.

Toa Pharmaceutical's Commitment

Through the launch of Biosthree® VC, Toa Pharmaceutical Industry continues its dedication to enhancing productivity and economic growth within the livestock sector. With a history dating back to 1948, the company remains at the forefront of veterinary pharmaceutical development, focusing on innovative solutions that promote better health outcomes for animals.

Company Overview

Established in January 1948, Toa Pharmaceutical Industry, headquartered in Shibuya, Tokyo, is a recognized leader in the development of pharmaceuticals, veterinary medicine, and health food products. The company is committed to improving livestock health and effectiveness through scientifically backed products.

Contact Information

For further inquiries regarding Biosthree® VC or other products, please reach out to:

• - Toa Pharmaceutical Industry, Animal Medicine Sales Department
• - Tel: 03-3375-0511
• - Email: [email protected]
• - Website: Toa Pharmaceutical

As livestock farmers look for sustainable and effective solutions, Biosthree® VC serves as a promising advancement in probiotic care for cattle, potentially transforming feeding practices within the industry.